Mukul Agrawal Portfolio Stock Gains Rs 14,28,00,000 in a Single Day as Shares Hit 20% Upper Circuit After Rs 200 Crore Greenfield Expansion Plan; Check Details

On Monday, Indian equity benchmarks traded lower, with the benchmark Nifty 50 index declining 115.10 points, or 0.47 per cent, to 24,219.20. Amid this broader market weakness, Tatva Chintan Pharma Chem share price was locked in the 20 per cent Upper Circuit, gaining Rs 285.60 to Rs 1,713.70. The stock also witnessed strong buying interest, with trading volumes reaching 21.7 lakh shares, significantly higher than its 30-day average volume of 1.21 lakh shares.

Why Did the Stock Rally?

The rally came after the company announced a Rs 200 crore investment to expand its Dahej-III greenfield manufacturing facility. The expansion will add 344 KL of reactor capacity and is expected to be completed over the next 21 months, strengthening the company's specialty chemicals manufacturing capabilities.

Mukul Mahavir Agrawal's Holding

According to the June 2026 shareholding pattern, Ace Investor Mukul Mahavir Agrawal held 5,00,000 equity shares, representing 2.14 per cent of the company's equity. With the stock gaining Rs 285.60 during Monday's trade, the value of his holding increased by approximately Rs 14,28,00,000 in a single trading session, based on the day's price increase.
Also Read - Specialty Chemical Company Approves Rs 200 Crore Greenfield Expansion Plan; Check the Details

Shareholding Pattern

As of the June 2026 quarter, promoters held 72.02 per cent stake in the company. Foreign Institutional Investors (FIIs) increased their holding to 3.93 per cent from 3.81 per cent in the previous quarter, while Domestic Institutional Investors (DIIs) held 3.11 per cent. Public shareholding stood at 20.94 per cent.

Share Price Performance

Tatva Chintan Pharma Chem has delivered strong momentum in recent weeks. The stock has gained approximately 45 per cent over the past four weeks, reflecting renewed investor interest following the company's expansion announcement and improving business outlook.

About Tatva Chintan Pharma Chem

Tatva Chintan Pharma Chem Limited is a specialty chemical manufacturer engaged in the production of phase transfer catalysts, structure-directing agents, electrolyte salts, pharmaceutical intermediates and other specialty chemicals. The company exports its products to customers across multiple global markets.

The company serves industries including pharmaceuticals, agrochemicals, energy storage and industrial chemicals, with a strong focus on research-driven product development and capacity expansion.

What are your views on Tatva Chintan Pharma Chem's sharp rally? Share your thoughts in the comments below.
Disclaimer: The article is for informational purposes only and should not be construed as investment advice.